Related Experiment Video
Updated: Mar 25, 2026

Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty
Published on: July 24, 2013
Recent Insights Into Cardiovascular Disease (CVD) Risk Among HIV-Infected Adults
Robert C Kaplan1, David B Hanna2, Jorge R Kizer2,3
1Department of Epidemiology and Population Health, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY, 10461, USA. robert.kaplan@einstein.yu.edu.
Insights
Even with treatment, adults with HIV face persistent cardiovascular disease (CVD) risks. HIV may also impact heart function and structure, potentially leading to heart failure and arrhythmias.
Area of Science:
- Infectious Diseases
- Cardiology
- Public Health
Background:
- Cardiovascular disease (CVD) mortality has declined in adults with HIV.
- However, excess CVD risk persists in HIV-infected individuals despite treatment and risk factor management.
- Emerging evidence links HIV to cardiac dysfunction, fibrosis, and fat infiltration.
Purpose of the Study:
- To review the evolving landscape of CVD in the context of HIV.
- To highlight non-atherosclerotic cardiac complications associated with HIV.
- To discuss the implications for clinical risk stratification and treatment guidelines.
Main Methods:
- Literature review of recent studies on HIV and cardiovascular disease.
- Analysis of trends in CVD mortality and morbidity among HIV-infected populations.
- Examination of the impact of highly active antiretroviral therapy (HAART) on cardiac health.
Main Results:
- HIV infection is associated with impaired left ventricular function and structural cardiac changes.
- Heart failure and arrhythmias may become more prevalent than coronary artery disease in aging HIV populations.
- The role of HIV in clinical CVD risk prediction remains unclear.
Conclusions:
- HIV-positive individuals may experience unique cardiovascular complications beyond traditional atherosclerosis.
- Cardiovascular risk assessment in HIV requires updated strategies.
- Further research is needed to integrate HIV status into CVD prevention guidelines.
Abstract:
While mortality rates related to cardiovascular disease (CVD) have decreased over time among adults with HIV, excess risk of CVD in the HIV-infected population may persist despite highly active antiretroviral therapy (HAART) treatment and aggressive CVD risk factor control. Beyond atherosclerotic CVD, recent studies suggest that HIV infection may be associated with left ventricular systolic and diastolic function, interstitial myocardial fibrosis, and increased cardiac fat infiltration. Thus, with the increasing average age of the HIV-infected population, heart failure and arrhythmic disorders may soon rival coronary artery disease as the most prevalent forms of CVD. Finally, the question of whether HIV infection should be considered in clinical risk stratification has never been resolved, and this question has assumed new importance with recent changes to lipid treatment guidelines for prevention of CVD.
More Related Videos
Related Concept Videos
Sexually Transmitted Infections
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Coronary Artery Disease IV: Preventive Measures
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Retrovirus Life Cycles
Coronary Artery Disease I: Introduction

